Feasibility Study of NMR Based Serum Metabolomic Profiling to Animal Health Monitoring: A Case Study on Iron Storage Disease in Captive Sumatran Rhinoceros (Dicerorhinus sumatrensis)

Miki Watanabe, Terri L Roth, Stuart J Bauer, Adam Lane, Lindsey E Romick-Rosendale, Miki Watanabe, Terri L Roth, Stuart J Bauer, Adam Lane, Lindsey E Romick-Rosendale

Abstract

A variety of wildlife species maintained in captivity are susceptible to iron storage disease (ISD), or hemochromatosis, a disease resulting from the deposition of excess iron into insoluble iron clusters in soft tissue. Sumatran rhinoceros (Dicerorhinus sumatrensis) is one of the rhinoceros species that has evolutionarily adapted to a low-iron diet and is susceptible to iron overload. Hemosiderosis is reported at necropsy in many African black and Sumatran rhinoceroses but only a small number of animals reportedly die from hemochromatosis. The underlying cause and reasons for differences in susceptibility to hemochromatosis within the taxon remains unclear. Although serum ferritin concentrations have been useful in monitoring the progression of ISD in many species, there is some question regarding their value in diagnosing hemochromatosis in the Sumatran rhino. To investigate the metabolic changes during the development of hemochromatosis and possibly increase our understanding of its progression and individual susceptibility differences, the serum metabolome from a Sumatran rhinoceros was investigated by nuclear magnetic resonance (NMR)-based metabolomics. The study involved samples from female rhinoceros at the Cincinnati Zoo (n = 3), including two animals that died from liver failure caused by ISD, and the Sungai Dusun Rhinoceros Conservation Centre in Peninsular Malaysia (n = 4). Principal component analysis was performed to visually and statistically compare the metabolic profiles of the healthy animals. The results indicated that significant differences were present between the animals at the zoo and the animals in the conservation center. A comparison of the 43 serum metabolomes of three zoo rhinoceros showed two distinct groupings, healthy (n = 30) and unhealthy (n = 13). A total of eighteen altered metabolites were identified in healthy versus unhealthy samples. Results strongly suggest that NMR-based metabolomics is a valuable tool for animal health monitoring and may provide insight into the progression of this and other insidious diseases.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Multivariate PCA analysis of serum…
Fig 1. Multivariate PCA analysis of serum metabolome from Sumatran rhinoceroses.
(A) PCA scores plots indicating the relationship between three rhinoceroses: Rhino-1 (red), Rhino-2 (blue), Rhino-3 (green), and their health status (x-healthy, ●-unhealthy). (B) The average PC scores of each animal corresponding to the plot (A). The error bars are indicating the standard deviations. (C) PCA scores plot (A) based on the health status of animals (x-Healthy-black, ●-Unhealthy). (D) The average scores of each animal corresponding to the plot (C). (E) PCA scores plots indicating the Rhino-1 health status (x-healthy, ●-unhealthy), and the average PC scores (F).
Fig 2. Univariate significant difference spectra (SDS)…
Fig 2. Univariate significant difference spectra (SDS) analysis.
SDS spectra obtained by subtracting the mean buckets (n = 980) of the unhealthy from healthy samples. Only the buckets (n = 178) with significant alterations based on t-test with FDR correction are plotted. BCAA: branched chain amino acids, 2HB: 2-hydroxyisobutyrate, Lac: lactate, Ala: alanine, Gln: glutamine, Cit: citrate, Cre: creatine, Gly: glycine, Glc: glucose, Man: mannose, Phe: phenylalanine.
Fig 3. Metabolite changes in relation to…
Fig 3. Metabolite changes in relation to health status of rhinoceroses.
Bucket intensities of each altered metabolite from three rhinoceroses: Rhino-1 (red), Rhino-2 (blue), Rhino-3 (green), and their health status (x-healthy, ●-unhealthy). The averages of all healthy or unhealthy samples are shown in black. (A) leucine, (B) isoleucine, (C) valine, (D) phenylalanine, (E) creatinine, (F) phosphocreatine.

References

    1. Dierenfeld ES, Atkinson S, Craig AM, Walker KC, Streich WJ, Clauss M. Mineral concentrations in serum/plasma and liver tissue of captive and free-ranging Rhinoceros species. Zoo Biology. 2005;24(1):51–72. 10.1002/zoo.20043
    1. Clauss M, Paglia DE. Iron storage disorders in captive wild mammals: the comparative evidence. Journal of zoo and wildlife medicine: official publication of the American Association of Zoo Veterinarians. 2012;43(3 Suppl):S6–18. Epub 2012/11/20. 10.1638/2011-0152.1 .
    1. Dierenfeld ES, Kilbourn A, Karesh W, Bosi E, Andau M, Alsisto S. Intake, utilization, and composition of browses consumed by the Sumatran rhinoceros (Dicerorhinus sumatrensis harissoni) in captivity in Sabah, Malaysia. Zoo Biology. 2006;25(5):417–31. 10.1002/zoo.20107
    1. Candra D, Radcliffe RW, Khan M, Tsu IH, Paglia DE. Browse Diversity And Iron Loading In Captive Sumatran Rhinoceroses (Dicerorhinus Sumatrensis): A Comparison Of Sanctuary And Zoological Populations. Journal of Zoo and Wildlife Medicine. 2012;43(3s):S66–S73. 10.1638/2011-0127.1
    1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature genetics. 1996;13(4):399–408. Epub 1996/08/01. 10.1038/ng0896-399 .
    1. Beutler E, West C, Speir JA, Wilson IA, Worley M. The HFE Gene of Browsing and Grazing Rhinoceroses: A Possible Site of Adaptation to a Low-Iron Diet. Blood Cells, Molecules, and Diseases. 2001;27(1):342–50. 10.1006/bcmd.2001.0386.
    1. Olias P, Mundhenk L, Bothe M, Ochs A, Gruber AD, Klopfleisch R. Iron overload syndrome in the black rhinoceros (Diceros bicornis): microscopical lesions and comparison with other rhinoceros species. Journal of comparative pathology. 2012;147(4):542–9. Epub 2012/09/01. 10.1016/j.jcpa.2012.07.005 .
    1. Roth TL. Development of a rhino ferritin specific assay for monitoring the progression of iron overload disorder in Sumatran rhinos (Dicerorhinus sumatrensis). Proceedings Workshop on Iron Overload Disorder in Browsing Rhinoceros, Progress Report, Pp14-15, Orlando, FL: 2016.
    1. Paglia DE, Tsu IH. Review of laboratory and necropsy evidence for iron storage disease acquired by browser rhinoceroses. Journal of zoo and wildlife medicine: official publication of the American Association of Zoo Veterinarians. 2012;43(3 Suppl):S92–104. Epub 2012/11/20. 10.1638/2011-0177.1 .
    1. Bundy J, Davey M, Viant M. Environmental metabolomics: a critical review and future perspectives. Metabolomics. 2009;5(1):3–21. 10.1007/s11306-008-0152-0
    1. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nature reviewsDrug discovery. 2002;1:153–61.
    1. Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics. 2011;12(1):103–11. Epub 2010/12/23. 10.2217/pgs.10.157 .
    1. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009;15:431–40.
    1. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annual review of pharmacology and toxicology. 2008;48:653–83. Epub 01/11. 10.1146/annurev.pharmtox.48.113006.094715 .
    1. Southam AD, Easton JM, Stentiford GD, Ludwig C, Arvanitis TN, Viant MR. Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks. Journal of proteome research. 2008;7:5277–85. 10.1021/pr800353t .
    1. Schock TB, Newton S, Brenkert K, Leffler J, Bearden DW. An NMR-based metabolomic assessment of cultured cobia health in response to dietary manipulation. Food Chem. 2012;133(1):90–101. .
    1. Schock TB, Duke J, Goodson A, Weldon D, Brunson J, Leffler JW, et al. Evaluation of Pacific White Shrimp (Litopenaeus vannamei) Health during a Superintensive Aquaculture Growout Using NMR-Based Metabolomics. PLoS One. 2013;8(3). .
    1. Schock TB, Stancyk DA, Thibodeaux L, Burnett KG, Burnett LE, Boroujerdi AFB, et al. Metabolomic analysis of Atlantic blue crab, Callinectes sapidus, hemolymph following oxidative stress. Metabolomics. 2010;6(2):250–62. .
    1. Jones OAH, Dondero F, Viarengo A, Griffin JL. Metabolic profiling of Mytilus galloprovincialis and its potential applications for pollution assessment. Marine Ecology Progress Series. 2008;369:169–79. 10.3354/meps07654
    1. Tuffnail W, Mills G, Cary P, Greenwood R. An environmental 1H NMR metabolomic study of the exposure of the marine mussel Mytilus edulis to atrazine, lindane, hypoxia and starvation. Metabolomics. 2009;5:33–43. 10.1007/s11306-008-0143-1
    1. Watanabe M, Meyer K, Jackson T, Schock T, Johnson WE, Bearden D. Application of NMR-based metabolomics for environmental assessment in the Great Lakes using zebra mussel (Dreissena polymorpha). Metabolomics. 2015;11(5):1302–15. 10.1007/s11306-015-0789-4
    1. Dove ADM, Leisen J, Zhou M, Byrne JJ, Lim-Hing K, Webb HD, et al. Biomarkers of Whale Shark Health: A Metabolomic Approach. PLoS ONE. 2012;7(11):e49379 10.1371/journal.pone.0049379
    1. Niemuth JN, Stoskopf MK. Hepatic metabolomic investigation of the North American black bear (Ursus americanus) using 1H-NMR spectroscopy. Wildlife Biology in Practice. 2014;10(1):14–23. 10.2461/wbp.2014.10.3
    1. Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts. NMR in biomedicine. 2008;21(8):809–19. 10.1002/nbm.1258
    1. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology. 1959;37(8):911–7. .
    1. Wu H, Southam AD, Hines A, Viant MR. High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Analytical biochemistry. 2008;372(2):204–12. 10.1016/j.ab.2007.10.002 .
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289–300.
    1. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the Human Metabolome Database. Nucleic acids research. 2007;35(Database issue):D521–6. 10.1093/nar/gkl923
    1. Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, et al. Metabolite identification via the Madison Metabolomics Consortium Database. Nature biotechnology. 2008;26(2):162–4. 10.1038/nbt0208-162 .
    1. Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, et al. BioMagResBank. Nucleic acids research. 2008;36(Database issue):D402–8. .
    1. Smith JE, Chavey PS, Miller RE. Iron Metabolism in Captive Black (Diceros bicornis) and White (Ceratotherium simum) Rhinoceroses. Journal of Zoo and Wildlife Medicine. 1995;26(4):525–31.
    1. Yamato M, Muto Y, Yoshida T, Kato M, Moriwaki H. Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. International Hepatology Communications. 1995;3(2):91–6. 10.1016/0928-4346(94)00159-3.
    1. Kuwahata M, Yoshimura T, Sawai Y, Amano S, Tomoe Y, Segawa H, et al. Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells. The Journal of nutritional biochemistry. 2008;19(7):438–47. Epub 2007/08/21. 10.1016/j.jnutbio.2007.05.011 .
    1. Nishitani S, Ijichi C, Takehana K, Fujitani S, Sonaka I. Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction. Biochem Biophys Res Commun. 2004;313(2):387–9. Epub 2003/12/20. .
    1. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007;6(3):181–94. Epub 2007/09/05. 10.1016/j.cmet.2007.08.003 ; PubMed Central PMCID: PMCPmc2693888.
    1. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun. 2002;299(5):693–6. Epub 2002/12/10. .
    1. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatology research: the official journal of the Japan Society of Hepatology. 2006;35(3):204–14. Epub 2006/06/02. 10.1016/j.hepres.2006.04.007 .
    1. Korenaga M, Nishina S, Korenaga K, Tomiyama Y, Yoshioka N, Hara Y, et al. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice. Liver international: official journal of the International Association for the Study of the Liver. 2015;35(4):1303–14. Epub 2014/08/27. 10.1111/liv.12675 ; PubMed Central PMCID: PMCPmc4409847.
    1. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet (London, England). 1979;2(8146):772–5. Epub 1979/10/13. .
    1. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. The Journal of nutrition. 2007;137(6 Suppl 1):1579S–85S; discussion 97S-98S. Epub 2007/05/22. .
    1. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg. 1974;127(1):40–7. Epub 1974/01/01. .
    1. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet (London, England). 1976;2(7991):880–2. Epub 1976/10/23. .
    1. Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World Journal of Gastroenterology: WJG. 2013;19(43):7620–9. 10.3748/wjg.v19.i43.7620 .
    1. Beben T, Rifkin DE. GFR Estimating Equations and Liver Disease. Advances in chronic kidney disease. 2015;22(5):337–42. Epub 2015/08/28. 10.1053/j.ackd.2015.05.003 ; PubMed Central PMCID: PMCPmc4552961.
    1. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Archives of internal medicine. 1994;154(2):201–5. Epub 1994/01/24. .
    1. MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: Are the equations for estimating renal function better? Canadian Journal of Gastroenterology. 2006;20(8):521–6. .
    1. Serra MA, Puchades MJ, Rodriguez F, Escudero A, del Olmo JA, Wassel AH, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scandinavian journal of gastroenterology. 2004;39(11):1149–53. Epub 2004/11/17. 10.1080/00365520410008024 .
    1. Parsons HM, Ekman DR, Collette TW, Viant MR. Spectral relative standard deviation: a practical benchmark in metabolomics. The Analyst. 2009;134:478–85. 10.1039/b808986h Epub 2008 Dec 2. .

Source: PubMed

3
Subskrybuj